Find Funding Opportunities

Notice Pre-application Informational Webinar RFA-NS-15-002 NINDS Morris K. Udall Centers Excellence Parkinson's Disease Research Program P50)" Notice Number: NOT-NS-15-010 Key Dates Release Date: January 9, 2015 Related Announcements RFA-NS-15-002 Issued National Institute Neurological Disorders Stroke NINDS) Purpose Notice to inform potential applicants RFA-NS-15-002 a pre-application webinar provide submission information the NINDS Morris K. Udall Centers Excellence Parkinson's Disease Research Program. intent the webinar to provide overview the initiative to address questions pertinent preparing applications. webinar optional not required application submission. Webinar Information Date: Thursday, January 15, 2015 Time: 2:00pm ET Meeting URL: https://global.gotomeeting.com/join/414962901 Call-in number: 213-493-0622 Participant passcode: 414-962-901 Questions be submitted email Udall2015@mail.nih.gov before during webinar; Please include Udall Webinar Question" the subject line. While every effort be to answer questions during webinar itself, due time constraints responses be sent afterwards. Space limited, the webinar directed specifically applicants the February 18, 2015 due date. Please one phone line per applicant institution. applicants strongly encouraged discuss applications the Scientific/Research contact early the application development process. complete text the FOA available http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-15-002.html. Inquiries Please direct inquiries to: Beth-Anne Sieber, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-5680 Email: sieberb@ninds.nih.gov Birgit Neuhuber, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-3562 Email: neuhuber@ninds.nih.gov

Notice Intent Publish Funding Opportunity Announcement the BRAIN Initiative: Clinical Studies Advance Next-Generation Invasive Devices Recording Modulation the Human Central Nervous System UH3) Notice Number: NOT-NS-15-007 Key Dates Release Date: December 17, 2014 Estimated Publication Date Announcement: January 2015 First Estimated Application Due Date: March 2015 Earliest Estimated Award Date: September, 2015 Earliest Estimated Start Date: September 2015 Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) National Eye Institute NEI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Drug Abuse NIDA) National Institute Mental Health NIMH) National Center Complementary Alternative Medicine NCCAM) Purpose NIH BRAIN Brain Research through Advancing Innovative Neurotechnologies) Initiative intends promote new initiative publishing Funding Opportunity Announcement FOA) solicit applications Clinical Studies Advance Next-Generation Invasive Devices Recording Modulation the Human Central Nervous System. Notice being provided allow potential applicants sufficient time develop meaningful collaborations responsive projects. FOA expected be published January 2015 an expected application due date Spring 2015. FOA utilize UH3 mechanism support small clinical studies will advance next generation recording and/or stimulating devices treat central nervous system disorders better understand human brain. Projects appropriate this FOA must completed non-clinical testing necessary obtain Investigational Device Exemption IDE) a Significant Risk SR) clinical study obtained Institutional Review Board IRB) approval a Non-Significant Risk NSR) clinical study prior entry. addition, projects must obtain necessary approval conduct clinical study prior entry within first year the award. total duration the award not exceed 5 years. companion FOA also expected be published January 2015, will support non-clinical testing required obtain necessary approvals conduct clinical study, addition a singular clinical study. summary the planned FOA provided below. Research Initiative Details FOA related Section III the BRAIN 2025 Report, addresses goal developing innovative technologies understand human brain treat disorders'. NIH recognizes initial first-in-man studies a key point the development innovative new clinical technologies. leap animal studies humans large, initial clinical studies often necessary address critical scientific questions the function a device human subjects and/or inform final device design suitable eventual FDA market approval. Initial demonstrations novel device function humans become increasingly required encourage industry venture capital investment necessary develop final safe, reliable, efficacious device can manufactured a scale suitable regulatory approval, yet a price point sufficient sustainable commercial market given insurance reimbursement. purpose this FOA to encourage applications pursue small clinical study obtain critical information necessary advance recording and/or stimulating devices treat central nervous system disorders better understand human brain e.g., Early Feasibility Study). Clinical studies supported consist acute short-term procedures are deemed Non-Significant Risk NSR) an Institutional Review Board, Significant Risk SR) studies require Investigational Device Exemption IDE) the FDA, such chronic implants. clinical study should provide data answer key questions the function final design a device. final device design require most, not all, the non-clinical testing the path more advanced clinical trials market approval. clinical study expected provide information cannot practically obtained through additional nonclinical assessments e.g., bench top animal studies) due the novelty the device its intended use. Examples the types clinical studies can proposed include, are limited to: Optimization the device design respect the human functional anatomy Identification the most simple, reliable, cost effective device configuration more advanced clinical trials eventual market approval Basic proof-of-concept testing human subjects Studies the key physiological variables may impact function the device humans Initial assessments device safety, only conjunction obtaining enabling data device design function. APPLICATIONS NOT BEING SOLICITED THIS TIME. Inquiries Please direct inquiries to: Kip Ludwig, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1447 Email: brain-initiative-FY15-FOA@mail.nih.gov

Notice Intent Publish Funding Opportunity Announcement the BRAIN Initiative: Next-Generation Invasive Devices Recording Modulation the Human Central Nervous System UH2/UH3) Notice Number: NOT-NS-15-008 Key Dates Release Date: December 17, 2014 Estimated Publication Date Announcement: January 2015 First Estimated Application Due Date: March 2015 Earliest Estimated Award Date: September 2015 Earliest Estimated Start Date: September 2015 Related Announcements None Issued National Institute Neurological Disorders Stroke NINDS) National Eye Institute NEI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Drug Abuse NIDA) National Institute Mental Health NIMH) National Center Complementary Alternative Medicine NCCAM) Purpose NIH BRAIN Brain Research through Advancing Innovative Neurotechnologies) Initiative intends promote new initiative publishing Funding Opportunity Announcement FOA) solicit applications Next-Generation Invasive Devices Recording Modulation the Human Central Nervous System. Notice being provided allow potential applicants sufficient time develop meaningful collaborations responsive projects. FOA expected be published January 2015 an expected application due date Spring 2015. FOA utilize UH2/UH3 mechanism support non-clinical testing a singular clinical study advance next generation recording and/or stimulation devices treat central nervous system disorders better understand human brain. UH2 phase support non-clinical testing necessary obtain necessary approvals a small clinical study, the UH3 phase support subsequent clinical study. companion stand-alone UH3 FOA also expected be published January, will support projects do require additional non-clinical testing obtain approval the clinical study. total duration the UH2 UH3 Phases combined not exceed 5 years. summary the planned FOA provided below. Research Initiative Details FOA related Section III the BRAIN 2025 Report, addresses goal developing innovative technologies understand human brain treat disorders'. NIH recognizes initial first-in-man studies a key point the development innovative new clinical technologies. leap animal studies humans large, initial clinical studies often necessary address critical scientific questions the function a device human subjects and/or inform final device design suitable eventual FDA market approval. Initial demonstrations novel device function humans become increasingly required encourage industry venture capital investment necessary develop final safe, reliable, efficacious device can manufactured scale suitable regulatory approval, yet a price point sufficient sustainable commercial market given insurance reimbursement. purpose this FOA to encourage applications pursue translational clinical studies obtain critical information necessary advance recording and/or stimulating devices treat central nervous system disorders better understand human brain. program utilize cooperative agreement mechanism support non-clinical testing necessary enable successful submission an Investigational Device Exemption IDE) a Significant Risk SR) study obtain Institutional Review Board IRB) approval a Non-Significant Risk NSR) study, the subsequent small clinical study e.g., Early Feasibility Study). clinical study should provide data answer key questions the function final design a device. final device design require most, not all, the non-clinical testing the path more advanced clinical trials market approval. clinical study expected provide information cannot practically obtained through additional nonclinical assessments e.g., bench top animal studies) due the novelty the device its intended use. Activities supported this program include implementation clinical prototype devices, non-clinical safety efficacy testing, design verification validation activities, pursuit regulatory approval for, implementation of, single small clinical study. projects have phases, UH2 an UH3 phase. initial UH2 phase support nonclinical testing support the submission an IDE an SR study to obtain IRB approval an NSR clinical study. projects start the UH2 phase, the length UH2 phase depend the maturity the project entry. Only those UH2 projects have met specific criteria outlined the FOA be eligible transition the second UH3 phase after NIH administrative review. UH3 phase support small clinical study. Clinical studies supported consist acute short-term NSR studies, SR studies such chronic implants. Examples the types clinical studies can proposed include, are limited to: Optimization the device design respect the human functional anatomy Identification the most simple, reliable, cost effective device configuration more advanced clinical trials eventual market approval Basic proof-of-concept testing human subjects Studies the key physiological variables may impact function the device humans Initial assessments device safety, only conjunction obtaining enabling data device design function. APPLICATIONS NOT BEING SOLICITED THIS TIME. Inquiries Please direct inquiries to: Kip Ludwig, PhD, National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1447 Email: brain-initiative-FY15-FOA@mail.nih.gov

Notice Frequently Asked Questions Webinar RFA-HL-15-021 Testing Multi-Level Interventions Improve Blood Pressure Control Minority Racial/Ethnic, Low Socioeconomic Status, and/or Rural Populations UH2/UH3)" Notice Number: NOT-HL-14-243 Key Dates Release Date: December 16, 2014 Related Announcements RFA-HL-15-021 Issued National Heart, Lung, Blood Institute NHLBI) National Institute Neurological Disorders Stroke NINDS) PCORI Addressing Disparities Program Addressing Disparities) Purpose purpose this Notice to inform potential applicants NHLBI hold webinar January 9, 2015, 10:30AM EST has posted set answers Frequently Asked Questions FAQs) regarding applications RFA-HL-15-021"Testing Multi-Level Interventions Improve Blood Pressure Control Minority Racial/Ethnic, Low Socioeconomic Status, and/or Rural Populations UH2/UH3)". webinar be available the following access information: Friday, January 9, 10:30AM-12:00PM EST https://webmeeting.nih.gov/r52wnlxf525/ Conference Number 1-877-701-3416 Participant Code: 567394 Frequently Asked Questions available this site: http://www.nhlbi.nih.gov/research/funding/opportunities/faq-foa-HL-15-0… applicants encouraged attend webinar view FAQs prior submitting application. Inquiries Please direct inquiries to: Larry Fine, M.D. National Heart, Lung, Blood Institute NHLBI) Telephone: 301-435-0305 Email:  finel@nhlbi.nih.gov Regina Hogle National Heart, Lung, Blood Institute NHLBI) Telephone: 301-451-6325 Email: regina.hogle@nih.gov

Notice Intent Publish Funding Opportunity Announcement BRAIN: Research Opportunities Using Invasive Neural Recording Stimulating Technologies the Human Brain U01) Notice Number: NOT-NS-15-002 Key Dates Release Date: December 8, 2014 Estimated Publication Date Announcement: January 2015 First Estimated Application Due Date: March 2015 Earliest Estimated Award Date: September, 2015 Earliest Estimated Start Date: September 2015 Related Announcements RFA-NS-15-005 Issued National Institute Neurological Disorders Stroke NINDS) National Eye Institute NEI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Drug Abuse NIDA) National Institute Mental Health NIMH) National Center Complementary Alternative Medicine NCCAM) Purpose NIH BRAIN initiative Brain Research through Advancing Innovative Neurotechnologies) intends promote new initiative publishing Funding Opportunity Announcement FOA) solicit applications research Research Opportunities Using Invasive Neural Recording Stimulating Technologies the Human Brain. Notice being provided allow potential applicants sufficient time develop meaningful collaborations responsive projects. FOA expected be published January 2015 an expected application due date Spring 2015. FOA utilize U01 activity code an award a 3 year project period. Details the planned FOA provided below. Research Initiative Details Human studies using invasive technology record modulate neural circuits require extensive planning expense. a result, studies often constrained a limited number patients resources available implement complex experimental protocols are rarely aggregated a matter sufficient address high-impact neuroscience questions appropriate power. Furthermore, small scale projects rarely identify retain additional sources data beyond primary endpoints, could of high value the wider scientific community. this FOA, NIH seeks address fundamental barriers supporting planning efforts exploratory research studies investigating high-impact questions human neuroscience disorders the human nervous system. Projects should develop multidisciplinary teams maximize opportunities conduct neuroscience research arising invasive surgical procedures provide unique ability record stimulate neurons within precisely localized brain structures humans. Integrated teams should consist clinicians, scientists, device engineers, mathematicians, statisticians, data scientists, regulatory specialists and/or ethics specialists. teams be assembled within single institution, may integrated across multiple institutions answer essential neuroscience questions appropriate statistical power. Awardees also join consortium, coordinated the NIH, identify consensus standards practice well supplemental opportunities collect data ancillary studies, to aggregate standardize data dissemination among wider scientific community. Applications span spectrum experimental studies mechanisms human sensory-motor, perceptual, cognitive, mnemonic, affective, motivational processes, disorders the human nervous system, studies mechanisms action device neuromodulation therapies. Applications should seek understand circuits the brain systematically controlling stimuli while actively recording manipulating relevant dynamic patterns neural activity by measuring resulting behaviors and/or perceptions. Novel innovative approaches theory analysis frameworks expected identify gaps knowledge, build testable hypothesis drive design experiments. Applications expected employ approaches guided specified theoretical constructs, are encouraged employ quantitative, mechanistic models where appropriate. Applications must propose appropriately-regulated, invasive studies humans, including intra-operative procedures during therapeutic/diagnostic implantation devices, short- long-term device implantation procedures. complementary animal component conduct reverse translation mechanistic questions, to perform forward translation tools techniques can only done animal models, be allowed. addition the proposed primary study endpoints, applications should propose solicit input the larger community identify prioritize additional sources data could obtained maximize value these limited opportunities, well generate consensus best practices common data standards data access data sharing including collection, curation, analysis sharing). APPLICATIONS NOT BEING SOLICITED THIS TIME. Inquiries Please direct inquiries to: James Gnadt, PhD National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-9964 Email: brain-initiative-FY15-FOA@mail.nih.gov

Notice Correction Regarding Companion Funding Opportunity Information PAR-14-286 quot;NINDS CREATE Bio Discovery Track: Optimization Preparation Development Biotechnology Products Biologics U01)" Notice Number: NOT-NS-15-003 Key Dates Release Date: December 8, 2014 Related Announcements PAR-14-286 Issued National Institute Neurological Disorders Stroke NINDS) Purpose Notice clarifies information regarding companion funding opportunities PAR-14-286 quot;NINDS CREATE Bio Discovery Track: Optimization Preparation Development Biotechnology Products Biologics U01)". Part 1. Overview Information FOA currently reads: Companion Funding Opportunity PAR-14-288, UH2/UH3 Phase Innovation Awards Cooperative Agreement PAR-14-287, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-Track PAR-14-289, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-Track FOA modified read: Companion Funding Opportunity PAR-14-288, UH2/UH3 Phase Innovation Awards Cooperative Agreement PAR-14-287, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Phase II, Fast-Track PAR-14-289, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-Track other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Hao Wang, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: CREATEinquiries@mail.nih.gov

Notice Correction Regarding Application Types Allowed PAR-14-287 quot;NINDS CREATE Bio Discovery Track: Optimization Preparation Development Biotechnology Products Biologics U44)" Notice Number: NOT-NS-15-004 Key Dates Release Date: December 8, 2014 Related Announcements PAR-14-287 Issued National Institute Neurological Disorders Stroke NINDS) Purpose Notice clarifies application types allowed PAR-14-287. Part 2. Section II. Award Information FOA currently reads: Application Types Allowed New Fast-Track) Renewal Fast-Track) Resubmission Fast-Track) Revision Fast-Track) FOA modified read: Application Types Allowed New Fast-Track) Renewal Phase II) Resubmission Fast-Track Phase II) Revision Fast-Track Phase II) other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Hao Wang, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: CREATEinquiries@mail.nih.gov

Notice Correction Regarding Companion Funding Opportunity Information PAR-14-288 quot;NINDS CREATE Bio Development Track: Preclinical Early-phase Clinical Development Biotechnology Products Biologics UH2/UH3)" Notice Number: NOT-NS-15-005 Key Dates Release Date: December 8, 2014 Related Announcements PAR-14-288 Issued National Institute Neurological Disorders Stroke NINDS) Purpose Notice clarifies information regarding companion funding opportunities PAR-14-288 quot;NINDS CREATE Bio Development Track: Preclinical Early-phase Clinical Development Biotechnology Products Biologics UH2/UH3)". Part 1. Overview Information FOA currently reads: Companion Funding Opportunity PAR-14-286, U01 Research Project ndash; Cooperative Agreements PAR-14-287, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-Track PAR-14-289, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-Track FOA modified read: Companion Funding Opportunity PAR-14-286, U01 Research Project ndash; Cooperative Agreements PAR-14-287, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Phase II, Fast-Track PAR-14-289, U44 Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-Track other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Hao Wang, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: CREATEinquiries@mail.nih.gov

Notice Correction Regarding Companion Funding Opportunity Information PAR-14-289 quot;NINDS CREATE Bio Development Track: Preclinical Early-phase Clinical Development Biotechnology Products Biologics U44)" Notice Number: NOT-NS-15-006 Key Dates Release Date: December 8, 2014 Related Announcements PAR-14-289 Issued National Institute Neurological Disorders Stroke NINDS)) Purpose Notice clarifies information regarding companion funding opportunities PAR-14-289 quot;NINDS CREATE Bio Development Track: Preclinical Early-phase Clinical Development Biotechnology Products Biologics U44)". Part 1. Overview Information FOA currently reads: Companion Funding Opportunity PAR-14-288, UH2/UH3) Exploratory/Developmental Cooperative Agreement Phase I/ Phase II PAR-14-286, U01) Research Projects - Cooperative Agreements PAR-14-287, U44) Small Business Innovation Research SBIR) Cooperative Agreement ndash; Fast-track only FOA modified read: Companion Funding Opportunity PAR-14-288, UH2/UH3) Exploratory/Developmental Cooperative Agreement Phase I/ Phase II PAR-14-286, U01) Research Projects - Cooperative Agreements PAR-14-287, U44) Small Business Innovation Research SBIR) Cooperative Agreement ndash; Phase II, Fast-Track other aspects the FOA remain unchanged. Inquiries Please direct inquiries to: Hao Wang, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-1779 Email: CREATEinquiries@mail.nih.gov

Notice Updates the National Robotics Initiative NRI) Notice Number: NOT-EB-14-008 Key Dates Release Date:   October 23, 2014 Related Announcements NOT-EB-15-008 NOT-EB-13-005 Issued National Institutes Health NIH) National Eye Institute NEI) National Institute Aging NIA) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) Office Behavioral Social Sciences Research OBSSR) National Science Foundation NSF) National Aeronautics Space Administration NASA) U.S. Department Agriculture USDA) Defense Advanced Research Projects Agency DARPA) Purpose Notice updates supersedes previous Guide Notice, NOT-EB-13-005, published the NIH Guide, October 29, 2013. NIH collaborating a multi-agency funding opportunity, National Robotics Initiative NRI) http://www.nsf.gov/funding//pgm_summ.jsp?pims_id=503641), whose goal to accelerate development use robots the United States work beside, cooperatively with, people http://www.nsf.gov/pubs/2015/nsf15505/nsf15505.htm).  Innovative robotics research applications emphasizing realization such co-robots working symbiotic relationships human partners supported multiple agencies the federal government including National Science Foundation NSF), National Aeronautics Space Administration NASA), National Institutes Health NIH), U.S. Department Agriculture USDA), the U.S. Department Defense DOD). purpose this program the development this next generation robotics, advance capability usability such systems artifacts, to encourage existing new communities focus innovative application areas. will address entire life cycle fundamental research development manufacturing deployment. Collaboration between academic, industry, non-profit other organizations strongly encouraged establish better linkages between fundamental science technology development, deployment use. NIH encourages robotics research technology development enhance health, lengthen life reduce illness disability. NIH also supports non-hypothesis driven applications, includes technology-driven problem-driven applications. Specifically, participating NIH Institutes Centers ICs) this solicitation interested targeting solicitation support development assistive robotic technology achieve functional independence humans; improve quality life; assist behavioral therapy personalized care; promote wellness/health. most significant challenges be addressing safety issues, especially applications be used home-based long-term care settings where integration complex systems be required. Additionally, assistive robots need quickly adapt changes the user the environment. Human assistive devices should designed assist healthcare providers as well the individuals needing care. Development robotic applications important NIH because their potential significant impact healthcare the future. Human assistive devices revolutionize healthcare the next 20 years much personal electronics changed our daily lives the past decades. Affordable accessible robotic technology facilitate wellness personalized healthcare. Continual health assessment personalized intervention the potential offset shrinking size the healthcare workforce the growing elderly disabled population. the future, assistive robotics enable people engage all aspects human life endurance dignity. Examples assistive robotic technology development include are limited to: - Homecare long-term personalized care robots - Robotic wellness/health promotion maintenance - Robotic behavioral therapy - Robotic aids mobility, manipulation, human communication cognition, vision non-sighted persons - Assistive robotics eliminate health disparities across populations developing appropriate assistive co-robotic technologies, applicants should consider following basic characteristics: effectiveness, affordability, cultural acceptability, accessibility those need them.  Applicants should describe these technologies address healthcare needs the end user healthy individuals, persons disability, or health disparity populations). robotic applications promoted this solicitation for non-operative settings.  NIH still interested supporting robotics surgical health interventions robotic exoskeletons, however, in response solicitation.  Applicants interested this area should send inquiries the NIH contacts listed below.  Award Information Award sizes NIH funded research projects expected range approximately 100,000 250,000 per year direct costs, durations one three years.  award exceed 250,000 per year direct costs. Applicants wish submit proposal NIH more 250,000 direct costs any grant should contact Program staff an NIH Institute/Center directly alternate proposal mechanisms.  Estimated program budget, number awards average award size duration subject the availability funds.  Determination awards based three criteria: 1) availability funds, 2) program priorities, 3) scientific merit. Subsequent grant administration procedures be accordance the policies the awarding Institute. Application Preparation Submission Instructions Applications submitted response this solicitation should prepared submitted accordance the general guidelines contained the NSF Grant Proposal Guide GPG).  Applications must submitted the NSF, to NIH.  complete text the GPG available electronically the NSF website http://www.nsf.gov/publications/pub_summ.jsp?ods_key=gpg. Applicants reminded identify NSF program announcement number the program announcement block the NSF Cover Sheet Proposal the National Science Foundation.  Compliance this announcement critical determining relevant application processing guidelines.  Failure submit information delay processing. Budgetary Information Cost sharing not required applications submitted this funding opportunity. Budgets should include travel funds the PD/PI team members attend annual NRI Principal Investigators' meeting. NIH Process goal this activity to involve multiple agencies using application one review. meet NIH requirements, those applications are identified potential funding participating NIH ICs, applicant organization be required submit R01 application an NIH-approved format.  PD/PIs invited submit NIH receive further information submission procedures the NIH. NIH application not allowed increase proposed budget change scientific content the application the converted submission the NIH. The summary statement be presented the involved IC's National Advisory Council the second level review. Subsequent the Council review, NIH ICs make funding determinations selected awards be made. Grant administration procedures NIH awardees, including those related New Early Stage Investigators http://grants.nih.gov/grants/new_investigators/) be accordance the policies NIH. Please note applications be submitted review the NSF January 14, 2015. PDs/PIs applications selected potential funding the participating NIH ICs be notified the end March 2015.  converted submission NIH be due April 7, 2015, will an extremely short conversion time.  applicant organization want work closely their Sponsored Programs Office assure timely submission during narrow submission window. earliest project start date be July 1, 2015. Inquiries Written telephone inquiries encouraged.  NIH Program contacts listed below. Please the NSF NRI website names contact information each the participating NSF Directorates, USDA, NASA DARPA http://www.nsf.gov/nri.   Grace C.Y. Peng, Ph.D., National Institute Biomedical Imaging Bioengineering NIBIB) Telephone: 301-451-4778;  Email: penggr@mail.nih.gov   Tom Greenwell, Ph.D. National Eye Institute NEI) Telephone: 301-451-2020 Email:  greenwellt@nei.nih.gov Lyndon Joseph, Ph.D National Institute Aging NIA) Telephone: 301-496-6926 Email: Josephlj@nia.nih.gov          Louis Quatrano, Ph. D. Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Telephone:  301-402-4221 Email: quatranl@mail.nih.gov Roger L. Miller, Ph.D. National Institute Deafness Other Communication Disorders NIDCD) Telephone: 301-402-3458 Email:  millerr@nidcd.nih.gov Daofen Chen, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-496-9964 Email: daofen.chen@nih.gov Augie Diana, Ph.D. National Institute Nursing Research NINR) Telephone: 301-402-6423 Email: dianaa@mail.nih.gov Wendy J. Nilsen, Ph.D. Office Behavioral Social Sciences Research OBSSR) Telephone:  301-496-0979 Email: nilsenwj@od.nih.gov